Evidence map›Paper›PMID 26146551›Full record

ArticleBiomaterials science2015

Redox-Responsive Self-Assembled Chain-Shattering Polymeric Therapeutics.

Kaimin Cai, Jonathan Yen, Qian Yin, Yang Liu, Ziyuan Song, Stéphane Lezmi, Yanfeng Zhang, Xujuan Yang, William G Helferich, Jianjun Cheng

Abstract read
In one paragraph

Article in Biomaterials science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments.Annual review of chemical and biomolecular engineering · 2018
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Anticancer nanoparticulate polymer-drug conjugate.Bioengineering & translational medicine · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kaimin CaiDepartment of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA.
Jonathan YenDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA.
Qian YinDepartment of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA.
Yang LiuDepartment of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA.
Ziyuan SongDepartment of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA.
Stéphane LezmiDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA.
Yanfeng ZhangDepartment of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA.
Xujuan YangDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA.
William G HelferichDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA.
Jianjun ChengDepartment of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA ; Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801, USA.

Funding

Developing Clinically Applicable, Cancer-Targeting Polymeric NanoconjugatesDP2OD007246 · OD · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI CHENG, JIANJUN · 2010 to 2010
$2.4M
Training the Next Generation of Researchers in Cancer Nanotechnology at the NCI MR25CA154015 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI BASHIR, RASHID, NARDULLI, ANN · 2010 to 2014
$1.5M
Camptothecin-Containing Nanoparticles: Control Over Particle Size, BiodistributioR21CA152627 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI CHENG, JIANJUN · 2011 to 2012
$334k
NCI NIH HHS 1R21CA152627NCI NIH HHS R21 CA152627NCI NIH HHS R25 CA154015NCI NIH HHS R25 CA154015ANIH HHS 1DP2OD007246-01NIH HHS DP2 OD007246
6 · The paper itself

Abstract

We report the design and development of redox-responsive chain-shattering polymeric therapeutics (CSPTs). CSPTs were synthesized by condensation polymerization and further modified with poly(ethylene glycol) (PEG) via "Click" reaction. Size-controlled CSPT nanoparticles (NPs) were formed through nanoprecipitation with high drug loading (up to 18%); the particle size increased in a concentration dependent manner. Drug release from particles was well controlled over 48 h upon redox triggering. The anticancer efficacy of the CSPT NPs was validated both in vitro and in vivo.

Indexed as

AnimalsCell SurvivalChemistry, PharmaceuticalDoxorubicinDrug CarriersDrug Delivery SystemsDrug LiberationHumansMCF-7 CellsMiceNanoparticlesOxidation-ReductionPaclitaxelParticle SizePolyethylene GlycolsPolymerizationDoxorubicinDrug CarriersPaclitaxelPolyethylene GlycolsPolymers

Identifiers

PMID26146551
PMCPMC4486357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.